Literature DB >> 16423

Inactivation of somatostatin by peptidases in different areas of the rat brain.

E C Griffiths, S L Jeffcoate, D T Holland.   

Abstract

With the availability of a sensitive and specific radioimmunoassay for growth hormone-release-inhibiting hormone (somatostatin or GH-RIH), it has been possible to investigate the presence of peptidase enzymes capable of inactivating this hypothalamic hormone in the hypothalamus and other brain areas of the rat. It was found that both supernatant and particulate fractions from male rat hypothalami rapidly inactivated somatostatin and that the enzymes involved have an optimum pH of 7.3. Peptidase activity was significantly higher in the supernatant than in the particulate fraction from the hypothalamus, thalamus, cortex and cerebellum. Besides confirming the presence of peptidases inactivating the release-inhibiting hormone in the hypothalamus (the site of somatostatin synthesis and release), the results may indicate that somatostatin has a functional significance outside the hypothalamus-anterior pituitary axis but within the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16423     DOI: 10.1530/acta.0.0850001

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

Review 1.  Endogenous somatostatin and the gut.

Authors:  M R Lucey
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

2.  Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion.

Authors:  M Utsumi; H Makimura; K Ishihara; S Morita; S Baba
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

3.  Somatostatin inhibits release of thyrotropin releasing factor from organ cultures of rat hypothalamus.

Authors:  Y Hirooka; C S Hollander; S Suzuki; P Ferdinand; S I Juan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.